Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 17, 2004
Tissue eosinophilia in pemphigoid gestationis: association with eotaxin and upregulated activation markers on transmigrated eosinophilsClaudia Günther, Gottfried Wozel, Jan Dressler, et al.
Dermatology (Basel, Switzerland)|August 16, 2008
Treatment following an evidence-based algorithm versus individualised symptom-oriented treatment for atopic eczema. A randomised controlled trialJochen Schmitt, Michael Meurer, Uta Schwanebeck, et al.
The Journal of Investigative Dermatology|August 12, 2006
Wavelength-dependent induction of CYP24A1-mRNA after UVB-triggered calcitriol synthesis in cultured human keratinocytesMichael Bär, Dörte Domaschke, Axel Meye, et al.
Experimental Dermatology|October 23, 2009
Lipidome of narrow-band ultraviolet B irradiated keratinocytes shows apoptotic hallmarksAdam Reich, Dominik Schwudke, Michael Meurer, et al.
The Annals of Pharmacotherapy|January 29, 2003
Macular exanthema due to fumaric acid estersClaudia H Guenther, Gottfried Wozel, Jörg Laske, et al.
Journal of Cellular and Molecular Medicine|July 16, 2008
Surface morphology and mechanical properties of fibroblasts from scleroderma patientsAdam Reich, Michael Meurer, Beate Eckes, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 16, 2005
[The use of high dose intravenous immunoglobulins in dermatology]Alexander Enk, Michael Hertl, Gerald Messer, et al.
Dermatology (Basel, Switzerland)|October 26, 2002
Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month studyMichael Meurer, Regina Fölster-Holst, Gottfried Wozel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 25, 2011
Efficacy of pimecrolimus 1% cream in the long term management of atopic hand dermatitis. A double-blind RCTAndrea Bauer, Nora Lange, Uwe Matterne, et al.
Pageof 5